HSPB5 engages multiple states of a destabilized client to enhance chaperone activity in a stress-dependent manner.

HSPB5 client binding crystallin molecular chaperone protein aggregation small heat shock protein (sHSP) stress response unfolded protein response (UPR) wHsp16.9 α-lactalbumin αB-crystallin

Journal

The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R

Informations de publication

Date de publication:
01 03 2019
Historique:
received: 26 03 2018
revised: 03 12 2018
pubmed: 21 12 2018
medline: 7 5 2019
entrez: 21 12 2018
Statut: ppublish

Résumé

Small heat shock proteins (sHSPs) delay protein aggregation in an ATP-independent manner by interacting with client proteins that are in states susceptible to aggregation, including destabilized states related to cellular stress. Up-regulation of sHSPs under stress conditions supports their critical role in cellular viability. Widespread distribution of sHSPs in most organisms implies conservation of function, but it remains unclear whether sHSPs implement common or distinct mechanisms to delay protein aggregation. Comparisons among various studies are confounded by the use of different model client proteins, different assays for both aggregation and sHSP/client interactions, and variable experimental conditions used to mimic cellular stress. To further define sHSP/client interactions and their relevance to sHSP chaperone function, we implemented multiple strategies to characterize sHSP interactions with α-lactalbumin, a model client whose aggregation pathway is well defined. We compared the chaperone activity of human αB-crystallin (HSPB5) with HSPB5 variants that mimic states that arise under conditions of cellular stress or disease. The results show that these closely related sHSPs vary not only in their activity under identical conditions but also in their interactions with clients. Importantly, under nonstress conditions, WT HSPB5 delays client aggregation solely through transient interactions early in the aggregation pathway, whereas HSPB5 mutants that mimic stress-activated conditions can also intervene at later stages of the aggregation pathway to further delay client protein aggregation.

Identifiants

pubmed: 30567736
pii: S0021-9258(20)39257-7
doi: 10.1074/jbc.RA118.003156
pmc: PMC6398148
doi:

Substances chimiques

CRYAB protein, human 0
Protein Aggregates 0
alpha-Crystallin B Chain 0
Lactalbumin 9013-90-5

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

3261-3270

Subventions

Organisme : NEI NIH HHS
ID : R01 EY017370
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM008268
Pays : United States

Informations de copyright

© 2019 Delbecq and Klevit.

Références

Mol Vis. 2004 Sep 08;10:655-62
pubmed: 15448619
Biophys Chem. 2010 Feb;146(2-3):108-17
pubmed: 19954880
Int J Biochem Cell Biol. 2012 Oct;44(10):1593-612
pubmed: 22750029
Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10611-6
pubmed: 12947045
EMBO J. 2012 Dec 12;31(24):4587-94
pubmed: 23188086
J Biol Chem. 2017 Jan 13;292(2):672-684
pubmed: 27909051
Nat Struct Mol Biol. 2010 Sep;17(9):1037-42
pubmed: 20802487
J Mol Biol. 2011 Oct 21;413(2):297-309
pubmed: 21839090
Methods Enzymol. 1998;290:350-65
pubmed: 9534175
Cell Stress Chaperones. 2017 Jul;22(4):569-575
pubmed: 28332148
J Biol Chem. 2001 Feb 16;276(7):5346-52
pubmed: 11096101
Mol Cell. 2015 Jun 18;58(6):1067-78
pubmed: 26009280
J Mol Cell Cardiol. 2005 Mar;38(3):433-44
pubmed: 15733903
Lancet. 2003 Apr 12;361(9365):1258-65
pubmed: 12699953
Curr Pharm Biotechnol. 2010 Feb;11(2):146-57
pubmed: 20166966
J Biol Chem. 1997 Oct 31;272(44):27722-9
pubmed: 9346914
Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10449-53
pubmed: 1438232
Elife. 2015 May 11;4:
pubmed: 25962097
PLoS One. 2012;7(5):e37256
pubmed: 22655036
J Biol Chem. 2003 Mar 21;278(12):10361-7
pubmed: 12529319
Biochemistry. 2015 Jul 21;54(28):4276-84
pubmed: 26098708
Biochem J. 2007 Jan 1;401(1):129-41
pubmed: 16928191
Nat Struct Biol. 2001 Dec;8(12):1025-30
pubmed: 11702068
Biochemistry (Mosc). 2015 Dec;80(13):1734-47
pubmed: 26878578
J Neurosci Res. 2008 May 1;86(6):1343-52
pubmed: 18061943
Nat Genet. 1998 Sep;20(1):92-5
pubmed: 9731540
J Biol Chem. 2006 Dec 29;281(52):39943-52
pubmed: 17090542
EMBO J. 1997 Feb 3;16(3):659-71
pubmed: 9034347
J Mol Biol. 1998 Mar 20;277(1):27-35
pubmed: 9514758
J Biol Chem. 2008 Sep 26;283(39):26634-42
pubmed: 18621732
Protein Sci. 1998 Sep;7(9):2004-11
pubmed: 9761482
Ann Thorac Surg. 2011 Jun;91(6):1907-13
pubmed: 21619989
J Neurochem. 2001 Feb;76(3):730-6
pubmed: 11158243
Proc Natl Acad Sci U S A. 1999 May 25;96(11):6137-42
pubmed: 10339554

Auteurs

Scott P Delbecq (SP)

From the Department of Biochemistry, University of Washington, Seattle, Washington 98195-7350.

Rachel E Klevit (RE)

From the Department of Biochemistry, University of Washington, Seattle, Washington 98195-7350 klevit@uw.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH